Trial Profile
A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2023
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Vulvodynia
- Focus Therapeutic Use
- 23 Oct 2018 Results comparing sexual function with controls published in the American Journal of Obstetrics and Gynecology
- 07 May 2018 Primary endpoint (Tampon Test Pain Intensity) has not been met, according to the results published in the Obstetrics and Gynecology
- 07 May 2018 Results published in the Obstetrics and Gynecology